original articlesgastrointestinal tumorsCirculating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients
gastrointestinal tumors
Under an Elsevier user license
open archive
Keywords
anti-angiogenetic therapy
biomarkers
circulating endothelial cells
clinical outcome
colorectal cancer
Cited by (0)
Copyright © 2010 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.